Dermira Inc (1934798D US)

Dermira, Inc. develops and commercializes dermatology therapies. The Company markets topical small molecule therapeutics that target acne, sebaceous gland hyperactivity, and inflammatory skin diseases. Dermira serves patients in the United States.